PHILADELPHIA, Jan. 26 /PRNewswire/ -- Liquent, Inc. today announced Omnicare Clinical Research has licensed LiquentConnect® - a hosted software as a service (SaaS) solution used to quickly and easily create, review, amend and submit regulatory dossiers. Omnicare Clinical Research is a leading Phase I to IV global contract research organization serving the biopharmaceutical and medical device industries.
LiquentConnect enables organizations to produce their own eCTD and non electronic submissions without investing in IT infrastructure. All software and hardware upgrades are managed and executed by Liquent. LiquentConnect is fully executable for eCTD, NeeS and CTD publishing.
"As portions of the industry shift toward SaaS, we are pleased to offer LiquentConnect, a SaaS solution publishing tool," said Rick Riegel, Liquent's Chief Executive Officer. "Liquent is committed to providing value-add solutions to our customers. LiquentConnect provides reliable, secure access to your dossiers from anywhere with an internet connection."
Omnicare Clinical Research selected Liquent and will be utilizing LiquentConnect as its hosted solution provider due to Liquent's depth of expertise within the regulatory and life-sciences industry. The benefits of implementing a fully-managed SaaS solution outweighed the time and resource investment required for other solutions.
"LiquentConnect provides our organization and our customers with project submission data that is safe and secure. Liquent provided us with a solution that is not only flexible, but one that we believe can expand to meet our needs and offer an efficient and cost-effective tool to address a variety of situations, from eCTD to NeeS to paper," said Dr. Martine Dehlinger-Kremer, Vice President of Global Regulatory Affairs for Omnicare Clinical Research.
About Omnicare Clinical Research
Established in 1985, Omnicare Clinical Research is a full-service CRO, with diverse therapeutic expertise and comprehensive clinical service offerings, supporting the pharmaceutical industry throughout every aspect of a clinical project. Furthermore, the Company features specialized expertise in phase I-III clinical services, clinical supplies packaging, labeling, storage and distribution services, and functional service provider relationships from its office locations in over 30 countries worldwide. Omnicare Clinical Research is a subsidiary of Omnicare, Inc. (NYSE: OCR), a leading provider of pharmacy services to long-term care facilities and other chronic care settings comprising approximately 1.4 million beds in 47 states, the District of Columbia and Canada. www.omnicareCR.com.
About Liquent, Inc.
Liquent regulatory solutions provide software and related regulatory and clinical services for the life sciences industry. These solutions and services help ensure clients meet the strict standards of regulatory authorities across the world helping them achieve quality, accuracy, and data integrity to deliver regulatory reports and submissions reliably and on time. For more information please visit, www.liquent.com.
SOURCE Liquent, Inc.
|SOURCE Liquent, Inc.|
Copyright©2010 PR Newswire.
All rights reserved